Your browser is no longer supported. Please, upgrade your browser.
Settings
MDCO The Medicines Company daily Stock Chart
MDCO [NASD]
The Medicines Company
Index- P/E- EPS (ttm)-9.15 Insider Own1.00% Shs Outstand73.40M Perf Week4.16%
Market Cap2.00B Forward P/E- EPS next Y-3.12 Insider Trans103.45% Shs Float70.66M Perf Month-10.46%
Income-654.50M PEG- EPS next Q-1.33 Inst Own- Short Float26.16% Perf Quarter-21.12%
Sales85.00M P/S23.57 EPS this Y48.60% Inst Trans-1.21% Short Ratio15.05 Perf Half Y-27.72%
Book/sh2.60 P/B10.50 EPS next Y64.10% ROA-47.90% Target Price49.18 Perf Year-24.50%
Cash/sh2.85 P/C9.59 EPS next 5Y- ROE-160.50% 52W Range25.40 - 55.95 Perf YTD-19.56%
Dividend- P/FCF- EPS past 5Y-22.20% ROI-27.60% 52W High-51.21% Beta0.72
Dividend %- Quick Ratio1.80 Sales past 5Y-19.10% Gross Margin34.20% 52W Low7.48% ATR1.12
Employees410 Current Ratio2.30 Sales Q/Q-55.10% Oper. Margin- RSI (14)34.75 Volatility3.29% 4.16%
OptionableYes Debt/Eq3.42 EPS Q/Q66.10% Profit Margin- Rel Volume1.31 Prev Close27.25
ShortableYes LT Debt/Eq3.42 EarningsJan 24 BMO Payout- Avg Volume1.23M Price27.30
Recom1.40 SMA20-5.58% SMA50-12.18% SMA200-30.61% Volume1,603,455 Change0.18%
Oct-24-17Initiated Guggenheim Buy $45
Aug-29-17Reiterated Chardan Capital Markets Buy $80 → $85
Dec-05-16Initiated H.C. Wainwright Buy $57
Nov-16-16Reiterated RBC Capital Mkts Outperform $45 → $52
Nov-08-16Reiterated RBC Capital Mkts Outperform $48 → $45
Mar-21-16Reiterated Chardan Capital Markets Buy $50 → $65
Nov-16-15Reiterated RBC Capital Mkts Outperform $46 → $48
Nov-04-15Initiated Chardan Capital Markets Buy $50
Aug-31-15Reiterated RBC Capital Mkts Outperform $39 → $46
Aug-28-15Upgrade Jefferies Hold → Buy
Jul-06-15Upgrade Mizuho Neutral → Buy $28 → $41
Apr-10-15Reiterated Mizuho Neutral $30 → $27.50
Mar-20-15Initiated Mizuho Neutral $30
Feb-13-14Reiterated RBC Capital Mkts Outperform $50 → $44
Dec-05-13Reiterated RBC Capital Mkts Outperform $41 → $50
Jun-21-13Resumed Oppenheimer Perform
Feb-21-13Reiterated WallachBeth Buy $30 → $38
Feb-05-13Reiterated RBC Capital Mkts Outperform $34 → $37
Nov-20-12Initiated Oppenheimer Outperform $35
Feb-23-12Reiterated RBC Capital Mkts Outperform $21 → $25
Dec-13-17 07:00AM  The Medicines Company to Host Investor Day on January 23, 2018 Business Wire
Dec-12-17 01:36PM  ETFs with exposure to The Medicines Co. : December 12, 2017 Capital Cube
Dec-08-17 08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Dec-04-17 01:00PM  [$$] Icahn Protege's Big Biotech Buys: Biogen, Medicines Barrons.com
Dec-01-17 08:30AM  Report: Exploring Fundamental Drivers Behind Lannett, Oclaro, Antares Pharma, Workday, The Medicines, and Celldex Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
07:30AM  Blog Exposure - Melinta Therapeutics to Acquire Infectious Disease Business from The Medicines Co. ACCESSWIRE
Nov-30-17 04:55PM  Medicines Company to Sell Infectious Disease Unit to Melinta Zacks
12:59PM  Oppenheimer Raises Its Prognosis For The Medicines Company Benzinga
09:25AM  Melinta Up After Deal for Medicines' Infectious Disease Unit -- Biotech Movers TheStreet.com
Nov-29-17 04:59PM  Here's How Alnylam Pharmaceuticals, Inc. Crushed It in 2017 Motley Fool
04:38PM  Why Medicines Co. Is Tumbling Despite $270 Million Deal Investor's Business Daily
09:47AM  The Medicines Company (MDCO): Time For A Financial Health Check Simply Wall St.
07:41AM  UPDATE: Medicines Co. agrees to sell infectious disease unit to Melinta Therapeutics MarketWatch
07:12AM  Deerfield Supports Melinta Therapeutics Acquisition of The Medicines Company's Infectious Disease Business with a $240 million Commitment to Melinta and a $100 million Commitment to The Medicines Company PR Newswire
07:00AM  The Medicines Company Announces Definitive Agreement to Sell its Infectious Disease Business Unit to Melinta Therapeutics Business Wire
07:00AM  Melinta Therapeutics Enters Into Agreement to Acquire Infectious Disease Business from The Medicines Company GlobeNewswire
Nov-27-17 08:07AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Nov-24-17 10:45AM  ETFs with exposure to The Medicines Co. : November 24, 2017 Capital Cube
Nov-23-17 08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Nov-21-17 07:00AM  Earnings Review and Free Research Report: The Medicines Reported Better Than Expected Earnings Results ACCESSWIRE
Nov-15-17 07:30AM  The Medicines Company Names Dr. Fred Eshelman as Executive Chairman; Appoints Geno Germano to Its Board of Directors Business Wire
Nov-13-17 12:45PM  ETFs with exposure to The Medicines Co. : November 13, 2017 Capital Cube
Nov-10-17 09:58AM  The Medicines Co. :MDCO-US: Earnings Analysis: Q3, 2017 By the Numbers : November 10, 2017 Capital Cube
08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Nov-09-17 07:35AM  The Medicines Company's PCSK9 Inhibitor Strategy: More Heart Patients Via Lower Pricing Forbes
Nov-08-17 11:47AM  Alnylam's (ALNY) Q3 Earnings, Revenues Miss Estimates Zacks
Nov-06-17 07:00AM  The Medicines Company and Alnylam Pharmaceuticals Announce Initiation of Phase III Clinical Trials of Inclisiran Business Wire
Oct-30-17 08:49AM  Implied Volatility Surging for The Medicines Company (MDCO) Stock Options Zacks
Oct-26-17 12:28PM  Medicines Company (MDCO) Reports Q3 Loss, Revenues Miss Zacks -9.08%
08:08AM  The Medicines Company Is Making A Dangerous Bet On A Drug To Lower LDL Cholesterol Forbes
02:39AM  Edited Transcript of MDCO earnings conference call or presentation 25-Oct-17 12:30pm GMT Thomson Reuters StreetEvents
Oct-25-17 09:28AM  MacroGenics Soars on Collaboration with Incyte -- Biotech Movers TheStreet.com
08:06AM  Medicines Co. shares surge 8% on planned restructuring, layoffs MarketWatch
07:49AM  Medicines Co. reports 3Q loss Associated Press
07:00AM  The Medicines Company Reports Third-Quarter 2017 Business and Financial Results Business Wire
Oct-20-17 07:00AM  The Medicines Company to Announce Third-Quarter 2017 Financial Results on October 25 Business Wire
Oct-17-17 10:38AM  Vabomere: Major Addition to The Medicines Companys Portfolio? Market Realist
09:10AM  The Medicines Company May See Improvement in Payer Access Market Realist
08:37AM  Inclisiran: Long-Term Growth Driver for The Medicines Company? Market Realist
07:30AM  Corbus Pharmaceuticals Appoints Paris Panayiotopoulos to Its Board of Directors Marketwired
Oct-16-17 05:05PM  The Medicines Company May Report Steep Revenue Decline in 2017 Market Realist
03:10PM  Analysts Recommendations for The Medicines Company in October Market Realist
Oct-13-17 11:40AM  The Medicines Co. Value Analysis (NASDAQ:MDCO) : October 13, 2017 Capital Cube
Oct-12-17 08:25AM  The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : October 12, 2017 Capital Cube
Oct-05-17 08:06AM  Should You Have The Medicines Companys (MDCO) In Your Portfolio? Simply Wall St.
07:00AM  The Medicines Company to Present New Data from TANGO II Study of VABOMERE (meropenem and vaborbactam) at IDWeek 2017 Business Wire
Oct-04-17 10:50AM  ETFs with exposure to The Medicines Co. : October 4, 2017 Capital Cube
Oct-02-17 08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Sep-28-17 04:30PM  The Medicines Company to Present Data at IDWeek 2017 on Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE (meropenem and vaborbactam) Business Wire
08:17AM  The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : September 28, 2017 Capital Cube
Sep-25-17 09:57AM  Gene Therapy: A Big Week for Many Names Barrons.com
Sep-22-17 10:41AM  The Medicines Co. Continues to Focus on Pipeline Development Zacks
Sep-18-17 08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Sep-13-17 06:56PM  ETFs with exposure to The Medicines Co. : September 13, 2017 Capital Cube
Sep-12-17 08:05AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Sep-11-17 01:09PM  The Medicines Co. :MDCO-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017 Capital Cube
Sep-08-17 11:10AM  The Medicines Co. breached its 50 day moving average in a Bearish Manner : MDCO-US : September 8, 2017 Capital Cube
Sep-02-17 08:11AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Sep-01-17 07:20AM  Corporate News Blog - FDA Grants Approval to The Medicines Co.s VABOMERE(TM) ACCESSWIRE
Aug-31-17 09:26AM  The Medicines Company's Infection Drug Vabomere Gets FDA Nod Zacks
08:42AM  Biotech Stock Roundup: CAR-T in Focus on Gilead-Kite Deal, Incyte Up on Baricitinib Update Zacks
Aug-30-17 01:22PM  Medicines Company Gets FDA Approval, Has 119% Upside According To This Analyst Benzinga -5.96%
09:46AM  Otonomy Shares Fall On Disappointing Phase 3 Data - Biotech Movers TheStreet.com
09:17AM  Medicines Co. shares surge 2.5% on FDA approval of drug for complicated UTIs MarketWatch
07:00AM  The Medicines Company Announces FDA Approval of VABOMERE (meropenem and vaborbactam) Business Wire
Aug-29-17 05:41PM  The Medicines Co's Inclisiran Positive in Extension Study Zacks
08:42AM  The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : August 29, 2017 Capital Cube
Aug-28-17 07:00AM  New, One-Year Data from ORION-1 Phase II Study of Inclisiran Extends Excellent Long-Term Efficacy and Safety Profile, Affirming Dose for Phase III Trials Business Wire
Aug-24-17 08:05AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Aug-16-17 02:25PM  Edited Transcript of MDCO earnings conference call or presentation 9-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
08:05AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Aug-15-17 08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Aug-12-17 08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Aug-11-17 08:05AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Aug-10-17 04:31PM  Alnylam (ALNY) Q2 Loss Narrower than Expected, Sales Miss Zacks
04:10PM  The Medicines Company (MDCO) Q2 Loss Widens, Revenues Miss Zacks
08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
Aug-09-17 10:59PM  Medicines Co. reports 2Q loss Associated Press
08:06AM  See what the IHS Markit Score report has to say about Medicines Co. Markit
07:00AM  The Medicines Company Reports Second Quarter 2017 Business and Financial Results Business Wire
05:30AM  Investor Network: Medicines Company to Host Earnings Call ACCESSWIRE
Aug-04-17 09:08PM  The Medicines Co. Value Analysis (NASDAQ:MDCO) : August 5, 2017 Capital Cube
Jul-31-17 07:00AM  The Medicines Company to Announce Second-Quarter 2017 Financial Results on August 9 Business Wire
Jul-26-17 08:15AM  Biotech Stock Roundup: Amgen, Biogen Top Q2 Estimates, Update on Incyte RA Drug Zacks
Jul-25-17 12:35PM  Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite TheStreet.com
07:00AM  The Medicines Company announces TANGO-2 trial of meropenem-vaborbactam (formerly, Carbavance) stopped early for superior benefit-risk compared to best available therapy for CRE Business Wire
Jul-24-17 08:28AM  The Medicines Co. breached its 50 day moving average in a Bullish Manner : MDCO-US : July 24, 2017 Capital Cube
Jul-10-17 04:50PM  Are Medicines Company's Key Drugs Set for Growth in 2017? Zacks
Jun-08-17 03:31AM  Why Is Alnylam (ALNY) Up 31.2% Since the Last Earnings Report? Zacks
Jun-07-17 12:15AM  Edited Transcript of MDCO earnings conference call or presentation 26-Apr-17 12:30pm GMT Thomson Reuters StreetEvents
May-31-17 12:01PM  Top Losers in the Healthcare Sector: May 2226, 2017 Market Realist +5.32%
May-30-17 04:30PM  The Medicines Company to Present Data at ASM Microbe 2017 on Infectious Disease Portfolio Including Late-Stage Investigational Antibiotic Meropenem-Vaborbactam Business Wire
May-25-17 10:27AM  Regeneron Presents Positive Phase II Data on HoFH Candidate Zacks
May-22-17 01:52PM  ETFs with exposure to The Medicines Co. : May 22, 2017 Capital Cube
May-16-17 04:51PM  This Funds Picks Gained 200% In A Year And Why No One Knows About It Insider Monkey
May-11-17 05:06PM  ETFs with exposure to The Medicines Co. : May 11, 2017 Capital Cube
May-09-17 11:19AM  The Medicines Co. :MDCO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 Capital Cube
May-08-17 01:59PM  Alnylam (ALNY) Q1 Loss Wider than Expected, Revenues Up Y/Y Zacks
08:47AM  Do Options Traders Know Something About Medicines Company (MDCO) Stock We Don't? Zacks
May-04-17 07:00AM  The Medicines Company to Participate in the Bank of America Merrill Lynch 2017 Health Care Conference Business Wire
The Medicines Company, a biopharmaceutical company, provides medicines for patients in acute and intensive care hospitals worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor used as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty, and for patients undergoing percutaneous coronary intervention; Ionsys, a fentanyl iontophoretic transdermal system for the short term management of acute postoperative pain for adults requiring opioid analgesia in the hospital. It also markets Minocin IV, an intravenous formulation of a tetracycline-class antibiotic used for the treatment of infections due to susceptible strains of designated gram-negative bacteria; and Orbactiv, an intravenous antibiotic used for the treatment of adult patients with acute bacterial skin and skin structure infections, or caused or suspected to be caused by susceptible isolates of designated gram-positive microorganisms. The company's approved products include Adenosine, Amiodarone, Esmolol, and Milrinone for acute cardiovascular; Azithromycin and Clindamycin for serious infectious disease; and Haloperidol, Midazolam, Ondansetron, and Rocuronium for surgery and perioperative treatment. Its research and development stage products comprise Carbavance, an antibiotic agent that has completed Phase III development stage for the treatment of hospitalized patients with serious gram-negative bacterial infections; Inclisiran, a synthesis inhibitor for the potential treatment of hypercholesterolemia; and MDCO-700, an intravenous anesthetic agent developed for moderate or deep sedation and general anesthesia in patients undergoing diagnostic or therapeutic procedures. The Medicines Company has a collaboration agreement with Alnylam Pharmaceuticals, Inc.; SciClone Pharmaceuticals; and Symbio Pharmaceuticals Limited. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ESHELMAN FREDRIC NExecutive ChairmanDec 08Buy26.65100,0002,665,0001,128,383Dec 11 06:23 PM
ESHELMAN FREDRIC NExecutive ChairmanDec 07Buy26.46100,0002,646,0001,028,383Dec 11 06:23 PM
Panayiotopoulos ParisDirectorNov 30Buy30.973,21599,5696,452Dec 01 05:47 PM
DENNER ALEXANDER JDirectorNov 29Buy30.03170,0005,105,1001,922,000Nov 30 07:30 AM
HUGIN ROBERT JDirectorNov 09Option Exercise15.7247,798751,228163,431Nov 13 06:18 PM
Spigelman Melvin KDirectorMay 23Option Exercise19.607,500147,00049,896May 25 05:08 PM
WYATT ELIZABETH H SDirectorMay 16Option Exercise19.607,500147,00049,896May 16 05:44 PM
CROUSE WILLIAMDirectorMay 12Option Exercise19.607,500147,00049,896May 16 05:42 PM
KESSLER ARMIN MDirectorMar 13Option Exercise19.607,500147,000147,756Mar 15 05:03 PM
HUGIN ROBERT JDirectorMar 08Option Exercise19.607,500147,000112,396Mar 10 04:56 PM
O'Connor William BernardChief Financial OfficerFeb 10Option Exercise24.6357,5021,416,03136,384Feb 14 05:46 PM
O'Connor William BernardChief Financial OfficerFeb 10Sale50.0057,5022,875,10020,102Feb 14 05:46 PM
O'Connor William BernardChief Financial OfficerFeb 07Option Exercise28.6015,000429,00035,102Feb 07 06:20 PM
O'Connor William BernardChief Financial OfficerFeb 07Sale47.0715,000706,06320,102Feb 07 06:20 PM
O'Connor William BernardChief Financial OfficerFeb 03Option Exercise22.0410,833238,75930,935Feb 07 06:20 PM
O'Connor William BernardChief Financial OfficerFeb 03Sale45.0010,833487,48520,102Feb 07 06:20 PM